OptimizeRx (OPRX) Total Current Liabilities: 2010-2024
Historic Total Current Liabilities for OptimizeRx (OPRX) over the last 15 years, with FY2024 value amounting to $18.7 million.
- OptimizeRx's Total Current Liabilities rose 2733.42% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year increase of 2733.42%. This contributed to the annual value of $18.7 million for FY2024, which is 431.72% up from last year.
- According to the latest figures from FY2024, OptimizeRx's Total Current Liabilities is $18.7 million, which was up 431.72% from $17.9 million recorded in FY2023.
- Over the past 5 years, OptimizeRx's Total Current Liabilities peaked at $18.7 million during FY2024, and registered a low of $8.4 million during FY2022.
- Over the past 5 years, OptimizeRx's median Total Current Liabilities value was $10.0 million (recorded in 2020), while the average stood at $12.9 million.
- Per our database at Business Quant, OptimizeRx's Total Current Liabilities plummeted by 1038.42% in 2022 and then surged by 11298.55% in 2023.
- Annual analysis of 5 years shows OptimizeRx's Total Current Liabilities stood at $10.0 million in 2020, then fell by 6.58% to $9.4 million in 2021, then fell by 10.38% to $8.4 million in 2022, then skyrocketed by 112.99% to $17.9 million in 2023, then rose by 4.32% to $18.7 million in 2024.
- Its Total Current Liabilities was $18.7 million in FY2024, compared to $17.9 million in FY2023 and $8.4 million in FY2022.